Piper Sandler重申了对CVS Health (NYSE:CVS)的增持评级，目标价保持在72.00美元。该公司的立场是在CVS Health宣布2024年第三季度医疗损失率（MLR）和每股收益（EPS）显著低于预期，并撤回2024年全年指引后做出的。为迅速应对这些挑战，CVS Health任命David Joyner为新任首席执行官，即刻生效。

CVS Health CEO Karen Lynch has stepped down and is being replaced by David Joyner amid struggles with rising costs.

Analysts question if CVS's new CEO David Joyner can resolve Aetna's high medical costs and improve performance after ...

CVS Health Chief Executive Officer Karen Lynch has stepped down and will be replaced by David Joyner, who runs the company's ...

CVS Health announced Friday it has appointed David Joyner as its new Chief Executive Officer, replacing Karen Lynch.

The industry-wide rise in health coverage costs makes the company's Aetna unit the new leader's most difficult problem.

Joyner, who heads CVS’s pharmacy-benefit business Caremark, will succeed Karen Lynch.

CVS Health on Friday replaced CEO Karen Lynch with David Joyner, a CVS veteran who retired before returning to the company ...

CVS Health said Friday that as of Thursday David Joyner became its new CEO, replacing Karen Lynch. In an agreement with the ...

The hits keep coming for CVS Health, which on Friday revealed new leadership and a bleaker-than-expected balance sheet. The ...

罗得岛州WOONSOCKET - CVS Health (NYSE:CVS) 宣布了一项重大领导层变动，David Joyner自上周四起担任总裁兼首席执行官。Joyner拥有37年的医疗保健和药房福利管理背景，接替Karen Lynch的职位。同时，Roger Farah从董事长转任为执行董事长。 Joyner此前曾担任CVS Health执行副总裁和CVS Caremark总裁。他在管理药房服 ...

Longtime executive David Joyner, 60, took over on Thursday after CVS repeatedly missed earnings targets, setting off unrest ...